Bilateral occlusive vasculitis after intravitreal injection of brolucizumab in neovascular age-related macular degeneration

被引:4
|
作者
Riedel, Anna Maria [1 ]
Lackerbauer, Carlo [2 ]
Lohmann, Chris P. [3 ]
Ulbig, Michael [3 ]
机构
[1] Ophthalmologikum Dr Neuhann, Residenzstr 9, D-80333 Munich, Germany
[2] Forum Bogenhausen, Praxis Augen Kompetenz Munchen, Richard Strauss Str 82, Munich, Germany
[3] Tech Univ Munchen TUM, Klinikum Rechts Isar, Klin & Poliklin Augenheilkunde, Ismaninger Str 22, D-81675 Munich, Germany
来源
OPHTHALMOLOGE | 2022年 / 119卷 / 01期
关键词
D O I
10.1007/s00347-021-01323-6
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
[No abstract available]
引用
收藏
页码:75 / 78
页数:4
相关论文
共 50 条
  • [1] Bilateral occlusive vasculitis after intravitreal injection of brolucizumab in neovascular age-related macular degeneration
    Riedel, Anna Maria
    Lackerbauer, Carlo
    Lohmann, Chris P.
    Ulbig, Michael
    [J]. OPHTHALMOLOGIE, 2022, 119 (01): : 75 - 78
  • [2] Full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration
    Lee, Sang Hyeok
    Lee, Mee Yon
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2024,
  • [3] Clinical Outcomes of Intravitreal Brolucizumab Injection for Refractory Neovascular Age-related Macular Degeneration
    Lee, Jun Young
    Park, No Hae
    Kwon, Han Jo
    Park, Sung Who
    Byon, Ik Soo
    [J]. JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2024, 65 (09): : 596 - 604
  • [4] Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
    Maggio, Emilia
    Alfano, Alessandro
    Mete, Maurizio
    Pertile, Grazia
    [J]. CASE REPORTS IN OPHTHALMOLOGY, 2022, 13 (03): : 736 - 743
  • [5] Factors Affecting Disease Stability After Intravitreal Brolucizumab Injection in Refractory Neovascular Age-related Macular Degeneration
    Ji, Yong-Sok
    Kim, Yung Hui
    Kim, Hyun Jee
    Lee, Jong Hoon
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [6] Factors Affecting Disease Stability After Intravitreal Brolucizumab Injection for Refractory Neovascular Age-Related Macular Degeneration
    Kim, Yung-Hwi
    Moon, Tae Kyu
    Ji, Yong-Sok
    [J]. OPHTHALMOLOGY AND THERAPY, 2024,
  • [7] Beidseitige okklusive Vaskulitis nach intravitrealer Injektion von Brolucizumab bei neovaskulärer altersbedingter MakuladegenerationBilateral occlusive vasculitis after intravitreal injection of brolucizumab in neovascular age-related macular degeneration
    Anna Maria Riedel
    Carlo Lackerbauer
    Chris P. Lohmann
    Michael Ulbig
    [J]. Der Ophthalmologe, 2022, 119 (1): : 75 - 78
  • [8] Intravitreal brolucizumab in neovascular age-related macular degeneration with limited response to aflibercept
    Hatz, Katja B.
    Cedro, Luca
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [9] Intravitreal Therapy in Bilateral Neovascular Age-Related Macular Degeneration
    Barthelmes, Daniel
    Walton, Richard J.
    Arnold, Jennifer J.
    Mcallister, Ian L.
    Simpson, Judy M.
    Campain, Anna
    Hunyor, Alex P.
    Guymer, Robyn
    Essex, Rohan W.
    Morlet, Nigel
    Gillies, Mark C.
    [J]. OPHTHALMOLOGY, 2014, 121 (10) : 2073 - 2074
  • [10] Aflibercept for Intravitreal Injection In Neovascular Age-Related Macular Degeneration
    Frampton, James E.
    [J]. DRUGS & AGING, 2012, 29 (10) : 839 - 846